| Pharmaceutical active ingredients: |
| Molsidomine |
| Available forms, composition and doses of Corvaton: |
| Injectable; Injection; Molsidomine 2 mg / mlTablets; Oral; Molsidomine 2 mgTablets; Oral; Molsidomine 4 mgTablets; Oral; Molsidomine 8 mg |
| Corvaton medical category: |
| Human:Vasodilating drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C01DX12 - Molsidomine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-AventisTherabel Pharma |